A2 Biotherapeutics, Founded By Amgen Vets, Gets $57M For Cell Therapies
socalTECH
NOVEMBER 6, 2019
Agoura Hills-based A2 Biotherapeutics , a biotechnology firm started by veterans of Amgen which is developing cell therapies for cancer patients, has raised $57M in a Series A funding round, the company said this week. The startup was founded by Scott Foraker and Alexander Kamb. READ MORE>>.
Let's personalize your content